Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for Helicobacter pylori eradication in dyspepsia

Saudi Journal of Gastroenterology

Volumn 15, Issue 4, 2009, Pages 225-228

  Agah, Shahram ^b   Shazad, Babak ^b   Abbaszadeh, Babak ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Azithromycin; Helicobacter pylori; Metronidazole; Quadruple therapy regimens

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BISMUTH; METRONIDAZOLE; OMEPRAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; DYSPEPSIA; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RAPID UREASE TEST; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; AZITHROMYCIN; BISMUTH; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; TREATMENT OUTCOME;

EID: 70349802016     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.56091     Document Type: Article

References (28)

1. Hunt RH, Mohamed AH. The current role of Helicobacter pylori eradication in clinical practice. Scand J Gastroenterol Suppl 1995;208:47-52.
2. Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdörffer E, O'Morain C, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH I study. Helicobacter 1996;1:138-144
3. Laine L, Frantz JE, Baker A, Neil GA. A United States multicentre trial of dual and proton pump inhibitor based triple therapies for Helicobacter pylori. Aliment Pharmacol Ther 1997;11:913-917
4. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. Gut 1997;41:8-13.
5. IARC. Schistosomes, liver flukes and Helicobacter pylori. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Geneva: WHO Publications; 1994. p. 61.
6. Sipponen P, Kimura K. Intestinal metaplasia, atrophic gastritis and stomach cancer: Trends over time. Eur J Gastroenterol 1994;6:79-83.
7. Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 1995;7:427-433
8. Malekzadeh R, Sotoudeh M, Derakhshan MH, Mikaeli J, Yazdanbod A, Merat S, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the North-West of Iran. J Clin Pathol 2004;57:37-42.
9. Marshall BJ, Armstrong JA, Francis GJ, Nokes NT, Wee SH. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion 1987;37:16-30.
10. Malfertheiner P, Mégraud F, O'Morain C, Hungin A P, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-180
11. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994;272:65-69
12. Siavoshi F, Pourkhajeh AH, Merat S, Asl-Soleimani H, Heydarian E, Khatibian M, Malekzadeh R. Susceptibility of various strains of Helicobacter pylori to selected agents. Arch Iranian Med 2000;3:60-63
13. Chey WD, Fisher L, Barnett J, Delvalle J, Elta GH, Hasler WL, et al. Low-v ersus high-dose azithromycin triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998;12:1263-1267
14. Mégraud F. H pylori antibiotic resistance: Prevalence, importance, and advances in testing. Gut 2004;53:1374-1384
15. Vakil N. Helicobacter pylori treatment: A practical approach. Am J Gastroenterol 2006;101:497-499
16. Vilaichone RK, Mahachai V, Graham DY. Helicobacter pylori diagnosis and management. Gastroenterol Clin North Am 2006;35:229-237
17. de Boer WA, Driessen WM, Jansz AR, Tytgat GN. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: Results of a randomized prospective single-centre study. Eur J Gastroenterol Hepatol 1995;7:1189-1194
18. Mikaeli J, Mir-Nasseri MM, Manafi-Anari A. Evaluation of OAMB quadruple therapy for Helicobacter pylori eradication in patients with peptic ulcer disease and gastroduodenitis [in Persian] 2004;44:84-89
19. Kaviani MJ, Malekzadeh R, Vahedi H, Sotoudeh M, Kamalian N, Amini M, et al. Various durations of a standard regimen (amoxicillin, metronidazole, colloidal bismuth subcitrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial. Eur J Gastroenterol Hepatol 2001;13:915-919
20. Blandizzi C, Malizia T, Gherardi G, Costa F, Marchi S, Marveggio C, et al. Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis. J Antimicrob Chemother 1998;42:75-82.
21. Silva FM, Eisig JN, Chehter EZ, da Silva JJ, Laudanna AA. Low efficacy of an ultra-short term, once-daily dose triple therapy with omeprazole, azithromycin, and secnidazole for Helicobacter pylori eradication in peptic ulcer. Rev Hosp Clin Fac Med Sao Paulo 2002;57:9-14.
22. Ivashkin V T, Lapina TL, Bondarenko OY, Sklanskaya OA, Grigoriev PY, Vasiliev Y V, et al. Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer. World J Gastroenterol 2002;8:879-882
23. Krichhoff RM, Laufen H, Schäcke G, Kirchhoff G, Gallo E. Determination of azithromycin in gastric biopsy samples. Int J Clin Pharmacol Ther 1999;37:361-364
24. Peitz U, Menegatti M, Vaira D, Malfertheiner P. The European meeting on Helicobacter pylori: Therapeutic news from Lisbon. Gut 1998;43:66-69.
25. Cammarota G, Tursi A, Papa A, Montalto M, Veneto G, Cuoco L, et al. Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxicillin and either clarithromycin or azithromycin. Aliment Pharmacol Ther 1996;10:997-1000. (Pubitemid 26412931)
26. Di Mario F, Dal Bó N, Grassi SA, Rugge M, Cassaro M, Donisi PM, et al. Azithromycin for the cure of Helicobacter pylori infection. Am J Gastroenterol 1996;91:264-267 (Pubitemid 26067332)
27. Ivashkin VT, Lapina TL, Bondarenko OY, Sklanskaya OA, Grigoriev PY, Vasiliev YV, et al. Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer. World J Gastroenterol 2002;8:879-882
28. Vcev A, Stimac D, Ivandi A,Vceva A, Takac B, Pezerovi D. Pantoprazole, amoxicillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer. Alimen Pharmacol Ther 2000;14:69-72.